moa of glp-1 agonists Mechanism action of Glucagon-like peptide-1 receptor: mechanisms and

107 This poses a significant challenge for both the pharmaceutical industry and research activities

Patrick Sweigert, a bariatric surgeon at the Ohio State University Wexner Medical Center, said in a news release.Were entering a new world of multidisciplinary care pathways and a new frontier of weight management that is important for patients and surgeons to think about, Sweigert added.Findings presented at medical meetings should be considered preliminary until published in a peer-reviewed journal.More informationJohn Hopkins Bloomberg School of Public Health has more on GLP-1 drug use among weight-loss surgery patients.SOURCE: American College of Surgeons, news release, Oct

Gas that won't stop

130 NeumillerJ